Estimated population wide benefits and risks in China of lowering sodium through potassium enriched salt substitution: modelling study
Matti Marklund(Tufts University), Jason Wu(The George Institute for Global Health), Raquel C. Greer(Johns Hopkins University), Frederick Cudhea(Tufts University), Laura K. Cobb(Vital Strategies), Maoyi Tian(Harbin Medical University), Di Zhao(Johns Hopkins University), Lawrence J. Appel(Johns Hopkins University), Dariush Mozaffarian(Tufts University), Bruce Neal(UNSW Sydney), Tammy M. Brady(Johns Hopkins University), Gitanjali Singh(Tufts University), Renata Micha(Tufts University), Kunihiro Matsushita(Johns Hopkins University), Liping Huang(UNSW Sydney)
Cited by 122
Related Papers
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k